Abdul Latif Jameel collaborates with Wellesta Holdings to launch Butterfly iQ+ in India
The innovative Butterfly iQ+ is the world’s first single probe, whole-body handheld point-of-care ultrasound solution
Abdul Latif Jameel Health, part of the international diversified family business Abdul Latif Jameel and Wellesta Holdings, a Singapore-headquartered company providing marketing and commercialisation support to the healthcare sector in South East Asia, India and partnering in MENA, announced a new agreement for the marketing and distribution of the Butterfly iQ+ point-of-care ultrasound device in India.
The innovative Butterfly iQ+ is the world’s first single probe, whole-body handheld point-of-care ultrasound solution. As part of its new agreement with Abdul Latif Jameel Health, Wellesta will register Butterfly iQ+ in India and start promoting and selling the product in the country in the fourth quarter of 2022, bringing this technology to a potential 1.2 million registered physicians in the country.
The Butterfly iQ+™ aims to remedy this situation. Fusing semiconductors, artificial intelligence, and cloud technology, Butterfly has made it possible to usher in a new era of medical imaging and with it, healthcare.
The new collaboration will offer greater distribution of Butterfly iQ+ to physicians in India thereby expanding the capabilities of the practitioners in making informed decisions thereby accelerating access to modern medical care for those who need it most.
Butterfly iQ+ is revolutionising medical imaging. It is a hand-held 4-in-1 single probe whole-body innovative point-of-care ultrasound device powered by the world’s only Ultrasound–on-Chip technology.
This point-of-care device with over 20 default pre-sets is compatible with both iOS and Android smart devices and comes complete with battery back, wireless charging, cloud storage, customized app., software, and AI support.
Hailed as potentially the ‘stethoscope of the future’, the Butterfly iQ+ transforms what can sometimes be complex processes, into one connected and integrated point-of-care ultrasound (POCUS) system to help collect advanced imaging, perform rapid assessments, and guide critical procedures. It allows the sharing of results seamlessly with doctors across the globe to help read and interpret scans.
Milan Paleja, CMD, Wellesta, said: “I am excited to partner with Abdul Latif Jameel Health to market Butterfly iQ+ in India to bring this breakthrough Ultrasound-on-Chip technology in the Butterfly probe to this market. Its versatile, innovative ultrasound solution will assist healthcare professionals to obtain point-of-care ultrasound-driven insights – – across the vast country with a geographically disperse population to improve access to primary healthcare.”
